Viewing Study NCT00447356


Ignite Creation Date: 2025-12-24 @ 11:20 PM
Ignite Modification Date: 2025-12-25 @ 9:02 PM
Study NCT ID: NCT00447356
Status: WITHDRAWN
Last Update Posted: 2013-05-13
First Post: 2007-03-12
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: High-Dose Interferon Alfa in Treating Patients With Stage II or StageIII Melanoma
Sponsor: Hackensack Meridian Health
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module